RecensMedical, Inc. (KOSDAQ:394420)

Market Cap	292.42B
Revenue (ttm)	8.83B +3,033.4%
Net Income	-19.12B
EPS	-2,890.00
Shares Out	10.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	341,263
Average Volume	784,394
Open	24,650
Previous Close	25,350
Day's Range	24,500 - 27,500
52-Week Range	17,550 - 39,900
Beta	n/a
RSI	52.75
Earnings Date	Jun 29, 2026

About RecensMedical

RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company’s products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 394420

Financial Performance

In 2025, RecensMedical's revenue was 8.83 billion, an increase of 41.05% compared to the previous year's 6.26 billion. Losses were -19.12 billion, 143.8% more than in 2024.